TriSalus Life Sciences (TLSIW) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.88, -2.23% vs the prior close of $0.90.
- Volume 8.60K shares, 2.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TLSIW dips 2.2% to $0.88 on 5.1x normal volume. Closed at $0.88, -2.23% vs the prior close of $0.90. Day range $0.70–$0.94, opened at $1.11.
TLSIW daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TLSIW dips 2.2% to $0.88 on 5.1x normal volume
- Closed at $0.88, -2.23% vs the prior close of $0.90. Day range $0.70–$0.94, opened at $1.11.
- Volume was 8.60K shares, 5.1x its 50-day average of 1.67K — unusually heavy trading.
- Price is -0.3% vs its 50-day average ($0.88) and -13.5% vs its 200-day average ($1.02).
- 52-week range $0.44–$1.85; today's close sits at 31% of that range, 52.4% below the 52-week high.
Oct 15, 2026 — TLSIW jumps 13.9% to $0.90 on 2.3x normal volume
- Closed at $0.90, +13.92% vs the prior close of $0.79. Day range $0.82–$0.90, opened at $0.82.
- Volume was 4.20K shares, 2.3x its 50-day average of 1.83K — unusually heavy trading.
- Price is +0.2% vs its 50-day average ($0.90) and -11.8% vs its 200-day average ($1.02).
- 52-week range $0.44–$1.85; today's close sits at 33% of that range, 51.4% below the 52-week high.
Oct 14, 2026 — TLSIW slides 19.4% to $0.79, a 1-month low on 3.8x normal volume
- Closed at $0.79, -19.39% vs the prior close of $0.98. Day range $0.79–$0.81, opened at $0.81.
- Volume was 6.50K shares, 3.8x its 50-day average of 1.71K — unusually heavy trading.
- Price is -12.0% vs its 50-day average ($0.90) and -22.8% vs its 200-day average ($1.02).
- 52-week range $0.44–$1.85; today's close sits at 25% of that range, 57.3% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — TLSIW ends flat (+0.0%) to $0.98, 5 down days in a row
- Closed at $0.98, +0.00% vs the prior close of $0.98. Day range $0.98–$0.98, opened at $0.98.
- Price is +8.9% vs its 50-day average ($0.90) and -4.5% vs its 200-day average ($1.03).
- 52-week range $0.44–$1.85; today's close sits at 38% of that range, 47.0% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — TLSIW ends flat (+0.0%) to $0.98, 4 down days in a row
- Closed at $0.98, +0.00% vs the prior close of $0.98. Day range $0.98–$0.98, opened at $0.98.
- Price is +9.3% vs its 50-day average ($0.90) and -4.8% vs its 200-day average ($1.03).
- 52-week range $0.44–$1.85; today's close sits at 38% of that range, 47.0% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — TLSIW ends flat (+0.0%) to $0.98, 3 down days in a row
- Closed at $0.98, +0.00% vs the prior close of $0.98. Day range $0.98–$0.98, opened at $0.98.
- Price is +9.8% vs its 50-day average ($0.89) and -5.2% vs its 200-day average ($1.03).
- 52-week range $0.44–$1.85; today's close sits at 38% of that range, 47.0% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — TLSIW ends flat (+0.0%) to $0.98
- Closed at $0.98, +0.00% vs the prior close of $0.98. Day range $0.98–$0.98, opened at $0.98.
- Price is +10.3% vs its 50-day average ($0.89) and -5.4% vs its 200-day average ($1.04).
- 52-week range $0.44–$1.85; today's close sits at 38% of that range, 47.0% below the 52-week high.
Oct 7, 2026 — TLSIW ends flat (+0.0%) to $0.98
- Closed at $0.98, +0.00% vs the prior close of $0.98. Day range $0.89–$0.98, opened at $0.89.
- Volume was 1.50K shares, 0.7x its 50-day average of 2.25K.
- Price is +10.8% vs its 50-day average ($0.88) and -5.6% vs its 200-day average ($1.04).
- 52-week range $0.44–$1.85; today's close sits at 38% of that range, 47.0% below the 52-week high.
Oct 6, 2026 — TLSIW jumps 15.3% to $0.98
- Closed at $0.98, +15.29% vs the prior close of $0.85. Day range $0.89–$0.98, opened at $0.96.
- Volume was 800 shares, 0.4x its 50-day average of 2.23K — lighter than usual.
- Price is +11.1% vs its 50-day average ($0.88) and -5.9% vs its 200-day average ($1.04).
- 52-week range $0.44–$1.85; today's close sits at 38% of that range, 47.0% below the 52-week high.
Oct 5, 2026 — TLSIW ends flat (+0.0%) to $0.85
- Closed at $0.85, +0.00% vs the prior close of $0.85. Day range $0.85–$0.85, opened at $0.85.
- Price is -3.2% vs its 50-day average ($0.88) and -18.6% vs its 200-day average ($1.04).
- 52-week range $0.44–$1.85; today's close sits at 29% of that range, 54.1% below the 52-week high.
Oct 2, 2026 — TLSIW rises 1.2% to $0.85 on 2.8x normal volume
- Closed at $0.85, +1.19% vs the prior close of $0.84. Day range $0.80–$0.90, opened at $0.84.
- Volume was 6.50K shares, 2.8x its 50-day average of 2.35K — unusually heavy trading.
- Price is -3.1% vs its 50-day average ($0.88) and -18.8% vs its 200-day average ($1.05).
- 52-week range $0.44–$1.85; today's close sits at 29% of that range, 54.1% below the 52-week high.
TLSIW latest news & SEC filings
Every SEC filing by or about TLSIW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cox Bryan F. sold 296 shares at $4.39 (≈$1.30K) on Oct 5, 2026; now holds 162,805
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Marshak Richard sold 325 shares at $4.39 (≈$1.43K) on Oct 5, 2026; now holds 127,994
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stevens Jennifer sold 316 shares at $4.39 (≈$1.39K) on Oct 5, 2026; now holds 123,794
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Szela Mary T had withheld for taxes 2,693 shares at $4.38 (≈$11.80K) on Oct 5, 2026; now holds 1,074,990
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $11.41M (prior year $11.21M) (+1.7% vs Jun 30, 2025)
- Net income: -$9.19M (prior year -$8.29M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.27) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade TLSIW
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 5, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.66% (largest 25.9%). That is a volatile stock.
- Liquidity: about 2.70K shares (≈$2.38K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.88 vs a range of $0.44–$1.85 (31% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 21 open-market buys, 4 sales; latest: Richard Marshak sold 543 shares on May 15, 2026.
- Latest filings: 8-K Sep 22, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 61.57M shares outstanding (Aug 4, 2026), +23.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
TLSIW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.11 | 0.94 | 0.70 | 0.88 | 8.60K |
| Oct 15, 2026 | 0.82 | 0.90 | 0.82 | 0.90 | 4.20K |
| Oct 14, 2026 | 0.81 | 0.81 | 0.79 | 0.79 | 6.50K |
| Oct 13, 2026 | 0.98 | 0.98 | 0.98 | 0.98 | 0 |
| Oct 12, 2026 | 0.98 | 0.98 | 0.98 | 0.98 | 0 |
| Oct 9, 2026 | 0.98 | 0.98 | 0.98 | 0.98 | 0 |
| Oct 8, 2026 | 0.98 | 0.98 | 0.98 | 0.98 | 0 |
| Oct 7, 2026 | 0.89 | 0.98 | 0.89 | 0.98 | 1.50K |
| Oct 6, 2026 | 0.96 | 0.98 | 0.89 | 0.98 | 800 |
| Oct 5, 2026 | 0.85 | 0.85 | 0.85 | 0.85 | 0 |
| Oct 2, 2026 | 0.84 | 0.90 | 0.80 | 0.85 | 6.50K |
| Oct 1, 2026 | 0.84 | 0.84 | 0.84 | 0.84 | 0 |
| Sep 30, 2026 | 0.76 | 0.85 | 0.55 | 0.84 | 7.70K |
| Sep 29, 2026 | 0.81 | 1.02 | 0.81 | 1.02 | 900 |
| Sep 28, 2026 | 0.81 | 0.81 | 0.81 | 0.81 | 0 |
| Sep 25, 2026 | 0.81 | 0.81 | 0.81 | 0.81 | 0 |
| Sep 24, 2026 | 0.81 | 0.81 | 0.74 | 0.81 | 3.00K |
| Sep 23, 2026 | 0.92 | 0.95 | 0.79 | 0.80 | 12.80K |
| Sep 22, 2026 | 0.88 | 0.88 | 0.88 | 0.88 | 0 |
| Sep 21, 2026 | 0.83 | 0.88 | 0.83 | 0.88 | 1.50K |
About TriSalus Life Sciences
TriSalus Life Sciences (TLSIW) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in WESTMINSTER, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1826667.
TLSIW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gary B. Gordon | Director | May 18, 2026 |
| Kerry R Hicks | Director | May 15, 2026 |
| David J Matlin | Director | May 15, 2026 |
| Michael P Stansky | Director | May 18, 2026 |
| Mary T Szela | CEO and President | Jul 1, 2026 |
| William Valle | Director | May 15, 2026 |
| Mats Wahlstrom | Director | May 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bryan F. Cox | Chief of Research | Mar 20, 2026 |
| Jodi Devlin | Chief of Clinical Operations | Mar 20, 2026 |
| Richard Marshak | Chief Commercial Officer | Jul 1, 2026 |
| Richard Henry Marshall | Chief Medical Officer | Jun 29, 2026 |
| David Patience | Chief Financial Officer | Jul 6, 2026 |
| Jennifer Stevens | Chief Regulatory Officer | Mar 20, 2026 |
| Mary T Szela | CEO and President | Jul 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mary T Szela | Buy | 39,682 | $2.59 |
| May 15, 2026 | Mary T Szela | Buy | 39,682 | $2.59 |
| May 15, 2026 | Mary T Szela | Buy | 39,682 | $2.59 |
TLSIW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $45.15M | $-39.23M | -1.84 | $-18.01M |
| Dec 31, 2024 | $29.43M | $-30.05M | -1.31 | $-40.84M |
| Dec 31, 2023 | $18.51M | $-59.36M | -6.77 | $-50.58M |
| Dec 31, 2022 | $12.40M | $-47.19M | -161.55 | $-32.31M |
| Dec 31, 2021 | — | $4.77M | — | $-1.74M |
Latest balance sheet: total assets $62.45M, total liabilities $55.90M, cash $46.29M (as of Jun 30, 2026).
TLSIW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $1.66 |
| May 12, 2026 | 8-K Item 2.02 (results) | $0.80 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $1.56 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $1.64 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $0.86 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $2.02 |
| May 15, 2025 | 8-K Item 2.02 (results) | $1.40 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $1.03 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $1.21 |
| Feb 3, 2025 | 8-K Item 2.02 (results) | $1.28 |
| Jan 23, 2025 | 8-K Item 2.02 (results) | $1.10 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $1.20 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TLSIW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.